Inhibition of Nod2 signaling and target gene expression by curcumin

Shurong Huang, Ling Zhao, Kihoon Kim, Seok Lee Dong, Daniel H. Hwang

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Nod2 is an intracellular pattern recognition receptor that detects a conserved moiety of bacterial peptidoglycan and subsequently activates proinflammatory signaling pathways. Mutations in Nod2 have been implicated to be linked to inflammatory granulomatous disorders, such as Crohn's disease and Blau syndrome. Many phytochemicals possess anti-inflammatory properties. However, it is not known whether any of these phytochemicals might modulate Nod2-mediated immune responses and thus might be of therapeutic value for the intervention of these inflammatory diseases. In this report, we demonstrate that curcumin, a polyphenol found in the plant Curcuma longa, and parthenolide, a sesquiterpene lactone, suppress both ligand-induced and lauric acid-induced Nod2 signaling, leading to the suppression of nuclear factor-κB activation and target gene interleukin-8 expression. We provide molecular and biochemical evidence that the suppression is mediated through the inhibition of Nod2 oligomerization and subsequent inhibition of downstream signaling. These results demonstrate for the first time that curcumin and parthenolide can directly inhibit Nod2-mediated signaling pathways at the receptor level and suggest that Nod2-mediated inflammatory responses can be modulated by these phytochemicals. It remains to be determined whether these phytochemicals possess protective or therapeutic efficacy against Nod2-mediated inflammatory disorders.

Original languageEnglish (US)
Pages (from-to)274-281
Number of pages8
JournalMolecular Pharmacology
Volume74
Issue number1
DOIs
StatePublished - Jul 2008

Fingerprint

Curcumin
Phytochemicals
Gene Expression
lauric acid
Pattern Recognition Receptors
Curcuma
Peptidoglycan
Sesquiterpenes
Polyphenols
Lactones
Interleukin-8
Crohn Disease
Transcriptional Activation
Anti-Inflammatory Agents
Ligands
Mutation
Therapeutics
parthenolide

ASJC Scopus subject areas

  • Pharmacology

Cite this

Huang, S., Zhao, L., Kim, K., Dong, S. L., & Hwang, D. H. (2008). Inhibition of Nod2 signaling and target gene expression by curcumin. Molecular Pharmacology, 74(1), 274-281. https://doi.org/10.1124/mol.108.046169

Inhibition of Nod2 signaling and target gene expression by curcumin. / Huang, Shurong; Zhao, Ling; Kim, Kihoon; Dong, Seok Lee; Hwang, Daniel H.

In: Molecular Pharmacology, Vol. 74, No. 1, 07.2008, p. 274-281.

Research output: Contribution to journalArticle

Huang, S, Zhao, L, Kim, K, Dong, SL & Hwang, DH 2008, 'Inhibition of Nod2 signaling and target gene expression by curcumin', Molecular Pharmacology, vol. 74, no. 1, pp. 274-281. https://doi.org/10.1124/mol.108.046169
Huang, Shurong ; Zhao, Ling ; Kim, Kihoon ; Dong, Seok Lee ; Hwang, Daniel H. / Inhibition of Nod2 signaling and target gene expression by curcumin. In: Molecular Pharmacology. 2008 ; Vol. 74, No. 1. pp. 274-281.
@article{d3ee17a8e43a40ebb60ca43c96bbce3d,
title = "Inhibition of Nod2 signaling and target gene expression by curcumin",
abstract = "Nod2 is an intracellular pattern recognition receptor that detects a conserved moiety of bacterial peptidoglycan and subsequently activates proinflammatory signaling pathways. Mutations in Nod2 have been implicated to be linked to inflammatory granulomatous disorders, such as Crohn's disease and Blau syndrome. Many phytochemicals possess anti-inflammatory properties. However, it is not known whether any of these phytochemicals might modulate Nod2-mediated immune responses and thus might be of therapeutic value for the intervention of these inflammatory diseases. In this report, we demonstrate that curcumin, a polyphenol found in the plant Curcuma longa, and parthenolide, a sesquiterpene lactone, suppress both ligand-induced and lauric acid-induced Nod2 signaling, leading to the suppression of nuclear factor-κB activation and target gene interleukin-8 expression. We provide molecular and biochemical evidence that the suppression is mediated through the inhibition of Nod2 oligomerization and subsequent inhibition of downstream signaling. These results demonstrate for the first time that curcumin and parthenolide can directly inhibit Nod2-mediated signaling pathways at the receptor level and suggest that Nod2-mediated inflammatory responses can be modulated by these phytochemicals. It remains to be determined whether these phytochemicals possess protective or therapeutic efficacy against Nod2-mediated inflammatory disorders.",
author = "Shurong Huang and Ling Zhao and Kihoon Kim and Dong, {Seok Lee} and Hwang, {Daniel H.}",
year = "2008",
month = "7",
doi = "10.1124/mol.108.046169",
language = "English (US)",
volume = "74",
pages = "274--281",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Inhibition of Nod2 signaling and target gene expression by curcumin

AU - Huang, Shurong

AU - Zhao, Ling

AU - Kim, Kihoon

AU - Dong, Seok Lee

AU - Hwang, Daniel H.

PY - 2008/7

Y1 - 2008/7

N2 - Nod2 is an intracellular pattern recognition receptor that detects a conserved moiety of bacterial peptidoglycan and subsequently activates proinflammatory signaling pathways. Mutations in Nod2 have been implicated to be linked to inflammatory granulomatous disorders, such as Crohn's disease and Blau syndrome. Many phytochemicals possess anti-inflammatory properties. However, it is not known whether any of these phytochemicals might modulate Nod2-mediated immune responses and thus might be of therapeutic value for the intervention of these inflammatory diseases. In this report, we demonstrate that curcumin, a polyphenol found in the plant Curcuma longa, and parthenolide, a sesquiterpene lactone, suppress both ligand-induced and lauric acid-induced Nod2 signaling, leading to the suppression of nuclear factor-κB activation and target gene interleukin-8 expression. We provide molecular and biochemical evidence that the suppression is mediated through the inhibition of Nod2 oligomerization and subsequent inhibition of downstream signaling. These results demonstrate for the first time that curcumin and parthenolide can directly inhibit Nod2-mediated signaling pathways at the receptor level and suggest that Nod2-mediated inflammatory responses can be modulated by these phytochemicals. It remains to be determined whether these phytochemicals possess protective or therapeutic efficacy against Nod2-mediated inflammatory disorders.

AB - Nod2 is an intracellular pattern recognition receptor that detects a conserved moiety of bacterial peptidoglycan and subsequently activates proinflammatory signaling pathways. Mutations in Nod2 have been implicated to be linked to inflammatory granulomatous disorders, such as Crohn's disease and Blau syndrome. Many phytochemicals possess anti-inflammatory properties. However, it is not known whether any of these phytochemicals might modulate Nod2-mediated immune responses and thus might be of therapeutic value for the intervention of these inflammatory diseases. In this report, we demonstrate that curcumin, a polyphenol found in the plant Curcuma longa, and parthenolide, a sesquiterpene lactone, suppress both ligand-induced and lauric acid-induced Nod2 signaling, leading to the suppression of nuclear factor-κB activation and target gene interleukin-8 expression. We provide molecular and biochemical evidence that the suppression is mediated through the inhibition of Nod2 oligomerization and subsequent inhibition of downstream signaling. These results demonstrate for the first time that curcumin and parthenolide can directly inhibit Nod2-mediated signaling pathways at the receptor level and suggest that Nod2-mediated inflammatory responses can be modulated by these phytochemicals. It remains to be determined whether these phytochemicals possess protective or therapeutic efficacy against Nod2-mediated inflammatory disorders.

UR - http://www.scopus.com/inward/record.url?scp=45749116149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749116149&partnerID=8YFLogxK

U2 - 10.1124/mol.108.046169

DO - 10.1124/mol.108.046169

M3 - Article

VL - 74

SP - 274

EP - 281

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -